MedTrace Logo

Airway Clearance and Bronchoalveolar Lavage for Bronchiectasis Patients With Exacerbation

NCT03643302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 189

Last updated 2020-10-08

No results posted yet for this study

Summary

No study have evaluated the efficacy and safety of airway clearance therapy (ACT) and bronchoalveolar lavage (BAL) under bronchoscope for bronchiectasis.

This study aimed to evaluate the clinical efficacy and safety of tran-bronchoscopy airway clearance and bronchoalveolar lavage in the treatment of moderate to severe bronchiectasis with acute exacerbation:A randomized, prospective cohort study.

Conditions

  • Bronchiectasis Adult

Interventions

DEVICE

Version BF-1T26 electronic bronchoscope

Interventions involving the therapy of airway clearance and bronchoalveolar lavage by Version BF-1T26 electronic bronchoscope

Sponsors & Collaborators

  • Shanghai Pulmonary Hospital, Shanghai, China

    lead OTHER

Principal Investigators

  • Jin-fu Xu · Shanghai Pulmonary Hospital, Shanghai, China

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2019-02-28
Completion
2019-03-18

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03643302 on ClinicalTrials.gov